Blog
RSS FeedPosted by Michael Wonder on 13 Apr 2021
Did Australia get it right on AstraZeneca?
14 April 2021 - The almost-total absence of criticism for Australia’s decision to preference Pfizer’s vaccine over AstraZeneca’s for people ...
Posted by Michael Wonder on 10 Apr 2021
Doctors stop offering AstraZeneca jabs over legal risk
11 April 2021 - Many of the nation’s GPs are refusing to offer AstraZeneca’s vaccine to people under 50 until ...
Posted by Michael Wonder on 08 Apr 2021
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns
8 April 2021 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the AstraZeneca COVID-19 vaccine in ...
Posted by Michael Wonder on 08 Apr 2021
‘Before end of this year’: Novavax COVID vaccine could be months away
8 April 2021 - Regulatory approvals for the third pillar of Australia’s vaccine strategy may not be obtained until the ...
Posted by Michael Wonder on 08 Apr 2021
Wider storage and transportation conditions for the Pfizer COVID-19 vaccine now approved
8 April 2021 - The Therapeutic Goods Administration has recently approved wider storage and transportation conditions for the Pfizer COVID-19 ...
Posted by Michael Wonder on 07 Apr 2021
TGA to review advertising of stem cell therapies to the Australian public
7 April 2021 - The Therapeutic Goods Administration, part of the Department of Health, is investigating the advertising of stem ...
Posted by Michael Wonder on 06 Apr 2021
Statement by Acting Australian Government Chief Medical Officer, Professor Michael Kidd and Head of the Therapeutic Goods Administration Adjunct Professor John Skerritt
2 April 2021 - Australia's vaccine safety and regulatory process is world class and people can be confident that vaccines ...
Posted by Michael Wonder on 30 Mar 2021
Terminal cancer patients denied new treatments due to slow TGA approval
31 March 2021 - Desperate cancer patients are begging Australia’s drugs regulator to save lives by speeding up approvals and cutting ...
Posted by Michael Wonder on 29 Mar 2021
Building a more robust medicine supply - proposals to help prevent, mitigate and manage medicine shortages
29 March 2021 - The Therapeutic Goods Administration is conducting a public consultation seeking feedback on reforms intended to help ...
Posted by Michael Wonder on 24 Mar 2021
Vertex receives Australian TGA approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to treat people with cystic fibrosis ages 12 years and older who have at least one F508del mutation
24 March 2021 - With this approval approximately 750 people living with cystic fibrosis in Australia will be newly eligible for ...
Posted by Michael Wonder on 24 Mar 2021
Super flu vaccine gets the go-ahead
24 March 2021 - A new type of cell-based influenza vaccine is available this winter that promises to be significantly ...
Posted by Michael Wonder on 23 Mar 2021
Melbourne made COVID-19 vaccine now available
23 March 2021 - The Melbourne manufactured AstraZeneca vaccine is now available for Australians, with the TGA this evening approving ...
Posted by Michael Wonder on 22 Mar 2021
ATAGI statement and clinical guidance on AstraZeneca COVID-19 vaccine following EMA safety review
19 March 2021 - This statement from the Australian Technical Advisory Group on Immunisation updates advice previous provided on 16 March. ...
Posted by Michael Wonder on 21 Mar 2021
TGA approves CSL - Seqirus to manufacture AstraZeneca COVID-19 vaccine in Australia
21 March 2021 - Earlier today, the Therapeutic Goods Administration approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia. ...
Posted by Michael Wonder on 21 Mar 2021
AstraZeneca vaccine allowed by government regulators to be produced in Australia
21 March 2021 - Astra Zeneca vaccines will be produced in Australia from now on after the regulators approved doses being ...